查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1825367

尼古丁口香糖市場：2025-2030 年預測

Nicotine Gum Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 145 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

尼古丁口香糖市場預計將從 2025 年的 18.72 億美元成長到 2030 年的 24.01 億美元，複合年成長率為 5.11%。

尼古丁口香糖是一種非處方 (OTC) 戒菸輔助產品，旨在幫助人們減少菸草消費量，最終戒除菸草。它透過釋放尼古丁，經由口腔黏膜吸收，進而緩解菸癮、戒斷症狀和衝動。尼古丁口香糖有 2 毫克、4 毫克和 6 毫克三種規格，可根據個人每日菸草消費量進行客製化。全球尼古丁口香糖市場正經歷成長，這得益於人們健康意識的增強、吸煙相關疾病的日益流行以及政府和非政府組織 (NGO) 的支持。然而，尼古丁口香糖的潛在副作用可能對市場擴張構成挑戰。

市場趨勢

尼古丁口香糖市場受多種關鍵趨勢驅動。其中一個關鍵促進因素是肺癌、冠狀動脈心臟病、口咽癌、食道癌、中風、類風濕性關節炎、類風濕性關節炎和免疫相關疾病等吸菸相關疾病的發生率不斷上升。人們對這些健康風險的認知不斷提高，推動了對尼古丁口香糖等戒菸輔助產品的需求。此外，全球反吸菸宣傳活動和公共衛生計劃，例如世界衛生組織 (WHO) 每年 5 月 31 日的世界無菸日，正在提高人們對菸草有害影響的認知，並鼓勵人們採用戒菸產品。無菸兒童宣傳活動等非政府組織進一步擴大了這些努力，並倡導在全球範圍內減少菸草使用，從而推動了對尼古丁口香糖的需求。

推動市場成長的另一個趨勢是戒菸療法的日益普及。無論是在已開發市場或新興市場，政府和非政府組織都在積極推廣尼古丁口香糖，以幫助菸癮者，尤其是青少年。尼古丁含片和口感柔滑的口香糖等產品創新也促進了市場成長。製造商正在加大研發投入，以豐富產品線，滿足消費者對有效且易於使用的戒煙輔助劑的偏好。都市化的加速和健康意識的增強進一步推動了此類產品的需求。

驅動程式

尼古丁口香糖市場的發展受到強勁的戒菸舉措和越來越多嘗試戒菸人士的推動。公眾意識提升宣傳活動和嚴格的禁煙法規正在推動戒菸輔助產品的需求。例如，世界無菸日和「無菸兒童宣傳活動」等全球舉措旨在教育大眾吸菸的健康風險，並鼓勵使用尼古丁口香糖來抑制吸菸慾望。製造商正在透過推出創新產品（例如改良質地的含片和口香糖）來支持這些舉措，以滿足不斷變化的消費者需求。吸菸相關疾病（尤其是肺癌）的盛行率不斷上升，進一步推動了對尼古丁口香糖的需求，將其作為減少菸草依賴的工具。

然而，尼古丁口香糖的副作用也可能導致市場面臨潛在限制，這可能會限制部分消費者群體的接受度。儘管如此，在公共衛生宣傳活動的支持下，全球戒菸試驗的人數不斷增加，這將繼續推動市場成長。

地理視角

預計在整個預測期內，北美仍將是尼古丁口香糖的主要市場。美國在該地區佔據主導地位，領先品牌專注於產品創新以滿足日益成長的需求。例如，Nicorette 最近推出了口感更滑順的尼古丁口香糖和冰薄荷潤喉糖，以滿足消費者對提升使用者體驗的偏好。這些新興市場的發展預計將維持北美市場的成長。

歐洲也佔了相當大的市場佔有率，德國、英國、法國和義大利等國的銷售強勁。各國政府正在優先考慮禁煙策略，這進一步推動了市場擴張。同時，預計亞太地區在預測期內的複合年成長率最高。推動這一成長的因素包括消費者對先進戒菸輔助產品的需求不斷成長、菸草公司之間競爭加劇以及商業機會不斷擴大。預計日本將引領該地區的成長，而中國和印度嚴格的禁煙法可能會刺激對尼古丁口香糖作為傳統菸草產品替代品的需求。

尼古丁口香糖市場預計將在日益增強的健康意識、吸煙相關疾病發病率上升以及強力的反吸煙舉措的推動下實現成長。北美和歐洲仍將是主要市場，而亞太地區預計將擁有強勁的成長潛力。儘管潛在的副作用帶來挑戰，但持續的研發和創新產品的推出預計將保持市場動能。為了抓住這些機遇，產業相關人員應專注於利用公共衛生宣傳活動並開發消費者友善產品。

本報告的主要優點

  • 深入分析：深入了解主要和新興地區的市場洞察，重點關注客戶群、政府政策和社會經濟因素、消費者偏好、垂直行業和其他細分市場。
  • 競爭格局：了解主要企業所採用的策略策略，並了解採用正確策略的市場滲透潛力。
  • 市場趨勢和促進因素：探索動態因素和關鍵市場趨勢以及它們將如何影響未來的市場發展。
  • 可行的建議：利用洞察力來制定策略決策，在動態環境中開闢新的業務流和收益。
  • 受眾廣泛：對於新興企業、研究機構、顧問、中小企業和大型企業來說，既有利又划算。

它有什麼用途？

產業和市場考量、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法律規範與影響、新產品開發、競爭影響

調查範圍

  • 2022 年至 2024 年的歷史數據和 2025 年至 2030 年的預測數據
  • 成長機會、挑戰、供應鏈前景、法律規範與趨勢分析
  • 競爭定位、策略和市場佔有率分析
  • 收益成長和預測細分市場和區域分析（包括國家）
  • 公司概況（尤其是財務狀況和關鍵發展）。

目錄

第1章執行摘要

第2章市場概述

  • 市場概況
  • 市場定義
  • 調查範圍
  • 市場區隔

第3章 經營狀況

  • 市場促進因素
  • 市場限制
  • 市場機遇
  • 波特五力分析
  • 產業價值鏈分析
  • 政策法規
  • 策略建議

第4章 技術展望

5. 尼古丁口香糖市集（按劑量）

  • 介紹
  • 2mg
  • 4mg

6. 尼古丁口香糖市集（依通路）

  • 介紹
  • 線上
  • 離線
    • 超級市場/大賣場
    • 便利商店
    • 藥局

第7章 尼古丁口香糖市集（依年齡層）

  • 介紹
  • 18至30歲
  • 30至50歲
  • 50歲或以上

8. 尼古丁口香糖市集（依地區）

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 其他
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 印尼
    • 泰國
    • 其他

第9章競爭格局及分析

  • 主要企業和策略分析
  • 市佔率分析
  • 合併、收購、協議和合作
  • 競爭對手儀表板

第10章：公司簡介

  • GlaxoSmithKline Plc
  • Johnson and Johnson
  • ITC Limited
  • Cipla
  • Perrigo Company Plc
  • Fertin Pharma
  • Alchem International
  • Haleon Group
  • Dr. Reddy's Laboratories Ltd.
  • British American Tobacco plc

第11章 附錄

  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關人員的主要利益
  • 調查方法
  • 簡稱
簡介目錄
Product Code: KSI061614362

The Nicotine Gum Market is expected to grow from USD 1.872 billion in 2025 to USD 2.401 billion in 2030, at a CAGR of 5.11%.

Nicotine gum serves as an over-the-counter (OTC) smoking cessation aid designed to assist individuals in reducing cigarette consumption and ultimately quitting tobacco use. By releasing nicotine absorbed through the oral mucosa, the gum helps alleviate cravings, withdrawal symptoms, and the urge to smoke. Available in 2 mg, 4 mg, and 6 mg strengths, the dosage is tailored to an individual's daily cigarette consumption. The global nicotine gum market is experiencing growth driven by rising health consciousness, increasing prevalence of smoking-related diseases, and supportive initiatives from governments and non-governmental organizations (NGOs). However, potential adverse effects of nicotine gum may pose challenges to market expansion.

Market Trends

The nicotine gum market is propelled by several key trends. A significant driver is the growing incidence of smoking-related illnesses, such as lung cancer, coronary heart disease, oropharyngeal and esophageal cancers, stroke, rheumatoid arthritis, tuberculosis, and immune-related disorders. Heightened awareness of these health risks has increased demand for smoking cessation aids like nicotine gum. Additionally, global anti-smoking campaigns and public health initiatives, such as the World Health Organization's "World No Tobacco Day" observed annually on May 31, promote awareness of tobacco's adverse effects and encourage the adoption of cessation products. NGOs like the Campaign for Tobacco-Free Kids further amplify these efforts, driving demand for nicotine gum by advocating for reduced tobacco use worldwide.

Another trend fueling market growth is the increasing adoption of smoking cessation therapies. Governments and NGOs in both developed and emerging markets are actively promoting nicotine gum to support tobacco-addicted individuals, particularly younger demographics. Product innovation, such as the development of nicotine lozenges and smoother-textured gums, also contributes to market expansion. Manufacturers are investing in research and development (R&D) to enhance product offerings, aligning with consumer preferences for effective and user-friendly cessation aids. Urbanization and rising health consciousness further bolster demand for these products.

Growth Drivers

The nicotine gum market is driven by robust anti-smoking initiatives and the growing number of individuals attempting to quit smoking. Public awareness campaigns and stringent anti-smoking regulations have heightened the demand for cessation aids. For example, global initiatives like World No Tobacco Day and the Campaign for Tobacco-Free Kids educate the public on smoking's health risks, encouraging the use of nicotine gum to manage cravings. Manufacturers support these efforts by introducing innovative products, such as lozenges and gums with improved textures, to meet evolving consumer needs. The rising prevalence of smoking-related diseases, particularly lung cancer, further drives demand for nicotine gum as a tool to reduce tobacco dependency.

However, the market faces potential constraints due to the adverse effects associated with nicotine gum, which may limit its adoption in some consumer segments. Despite this, the increasing number of quit attempts globally, supported by public health campaigns, continues to drive market growth.

Geographical Outlook

North America is projected to remain the leading market for nicotine gum throughout the forecast period, driven by a growing base of health-conscious consumers and supportive government initiatives. The United States dominates this region, with major brands focusing on product innovation to meet rising demand. For instance, Nicorette recently introduced a smoother-textured nicotine gum and an ice mint lozenge, catering to consumer preferences for enhanced user experience. These developments are expected to sustain market growth in North America.

Europe also holds a significant market share, with strong sales in countries such as Germany, the United Kingdom, France, and Italy. Regional governments are prioritizing smoking cessation strategies, further supporting market expansion. Meanwhile, the Asia Pacific region is anticipated to experience the highest compound annual growth rate (CAGR) over the forecast period. Factors driving this growth include increasing consumer demand for advanced cessation products, heightened competition among tobacco companies, and expanding commercial opportunities. Japan is expected to lead regional growth, while stringent anti-smoking laws in China and India are likely to boost demand for nicotine gum as an alternative to traditional tobacco products.

The nicotine gum market is poised for growth, driven by rising health awareness, increasing smoking-related illnesses, and robust anti-smoking initiatives. North America and Europe remain key markets, while Asia Pacific is expected to exhibit strong growth potential. Despite challenges from potential side effects, ongoing R&D and innovative product launches are likely to sustain market momentum. Industry stakeholders should focus on leveraging public health campaigns and developing consumer-friendly products to capitalize on these opportunities.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Nicotine Gum Market Segments:

By Dosage Type

  • 2 Mg
  • 4 Mg

By Distribution Channel

  • Online
  • Offline
  • Supermarket/Hypermarket
  • Convenience Stores
  • Pharmacies

By Age

  • 18 to 30 Years
  • 30 to 50 Years
  • Greater than 50 Years

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. NICOTINE GUM MARKET BY DOSAGE TYPE

  • 5.1. Introduction
  • 5.2. 2 Mg
  • 5.3. 4 Mg

6. NICOTINE GUM MARKET BY DISTRIBUTION CHANNEL

  • 6.1. Introduction
  • 6.2. Online
  • 6.3. Offline
    • 6.3.1. Supermarket/Hypermarket
    • 6.3.2. Convenience Stores
    • 6.3.3. Pharmacies

7. NICOTINE GUM MARKET BY AGE

  • 7.1. Introduction
  • 7.2. 18 to 30 Years
  • 7.3. 30 to 50 Years
  • 7.4. Greater than 50 Years

8. NICOTINE GUM MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. USA
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. Germany
    • 8.4.2. France
    • 8.4.3. United Kingdom
    • 8.4.4. Spain
    • 8.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. UAE
    • 8.5.3. Israel
    • 8.5.4. Others
  • 8.6. Asia Pacific
    • 8.6.1. China
    • 8.6.2. India
    • 8.6.3. Japan
    • 8.6.4. South Korea
    • 8.6.5. Indonesia
    • 8.6.6. Thailand
    • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. GlaxoSmithKline Plc
  • 10.2. Johnson and Johnson
  • 10.3. ITC Limited
  • 10.4. Cipla
  • 10.5. Perrigo Company Plc
  • 10.6. Fertin Pharma
  • 10.7. Alchem International
  • 10.8. Haleon Group
  • 10.9. Dr. Reddy's Laboratories Ltd.
  • 10.10. British American Tobacco plc

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key benefits for the stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations